1.82
price down icon2.67%   -0.05
pre-market  Pre-mercato:  1.82  
loading
Precedente Chiudi:
$1.87
Aprire:
$1.87
Volume 24 ore:
179.46K
Relative Volume:
0.52
Capitalizzazione di mercato:
$56.78M
Reddito:
$1.05M
Utile/perdita netta:
$-48.82M
Rapporto P/E:
-0.9945
EPS:
-1.83
Flusso di cassa netto:
$-47.49M
1 W Prestazione:
+12.35%
1M Prestazione:
+7.06%
6M Prestazione:
+41.09%
1 anno Prestazione:
-76.49%
Intervallo 1D:
Value
$1.75
$1.87
Intervallo di 1 settimana:
Value
$1.63
$1.89
Portata 52W:
Value
$1.06
$8.09

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Nome
Actinium Pharmaceuticals Inc
Name
Telefono
646-767-3870
Name
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Name
Dipendente
25
Name
Cinguettio
@actiniumpharma
Name
Prossima data di guadagno
2025-07-28
Name
Ultimi documenti SEC
Name
ATNM's Discussions on Twitter

Confronta ATNM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.82 58.34M 1.05M -48.82M -47.49M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-07 Downgrade B. Riley Securities Buy → Neutral
2024-05-14 Iniziato Stephens Overweight
2023-09-06 Iniziato HSBC Securities Buy
2023-02-21 Downgrade William Blair Outperform → Mkt Perform
2022-09-08 Iniziato Cantor Fitzgerald Overweight
2022-08-25 Iniziato B. Riley Securities Buy
2020-11-05 Iniziato Alliance Global Partners Buy
2017-12-06 Iniziato B. Riley FBR, Inc. Buy
2017-10-23 Ripresa ROTH Capital Buy
2017-09-14 Iniziato Maxim Group Buy
2016-08-25 Iniziato ROTH Capital Buy
2016-02-29 Iniziato H.C. Wainwright Buy
2015-10-15 Iniziato FBR Capital Outperform
2014-10-01 Iniziato MLV & Co Buy
2014-07-22 Iniziato Canaccord Genuity Buy
Mostra tutto

Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie

pulisher
Jul 24, 2025

What institutions are buying Actinium Pharmaceuticals Inc. stock nowFree Wealth Management Insights - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Actinium Pharmaceuticals Inc. stock priceRecord-breaking gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Actinium Pharmaceuticals Inc. stock outlookUnbelievable profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Actinium Pharmaceuticals Inc. a good long term investmentFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Actinium Pharmaceuticals Inc. stockMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView

Jul 21, 2025
pulisher
Jul 17, 2025

Is Actinium Pharmaceuticals Inc. stock a growth or value playFree Access to Investment Community - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

Actinium Highlights ATNM 400 Progress at SNMMI Conference - ca.finance.yahoo.com

Jul 02, 2025
pulisher
Jun 30, 2025

Actinium’s ATNM-400 demonstrates superior efficacy in prostate cancer - BioWorld MedTech

Jun 30, 2025
pulisher
Jun 23, 2025

Innovative Prostate Cancer Treatment ATNM-400 Shows Promising Pr - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire

Jun 23, 2025
pulisher
Jun 19, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Jun 19, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Increases Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire

May 28, 2025
pulisher
May 27, 2025

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire

May 27, 2025
pulisher
May 26, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 26, 2025
pulisher
May 26, 2025

FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse

May 26, 2025
pulisher
May 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar

May 26, 2025
pulisher
May 26, 2025

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse

May 26, 2025
pulisher
May 26, 2025

Press releases provided by CNW - Techaeris

May 26, 2025
pulisher
May 25, 2025

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune

May 25, 2025

Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):